Stock fact sheet · data as of

Rockwell Medical, Inc. (RMTI): fair value, margin of safety and Wheel Score

Ticker symbol RMTI · Healthcare · Drug Manufacturers - Specialty & Generic · United States · Speculative

Close8.05
GLS fair value9.841 of 9 models
Margin of safety+18%price below fair value
Wheel Score17Weakfails 7 filters
Health5/9Piotroski F-score
Moat0.8/10GLS 10-year score
Market cap$32M17k shares a day
Implied vol.500%near-the-money, 20-60 d
P/E-EPS -1.28
Dividend yieldnone
Beta1.73moves more than the market
Next earnings12 Nov 2026in 7 days (before the open)

Is RMTI undervalued?

At 8.05 (close of 5 Nov 2026), RMTI trades 18% under the GLS average fair value of 9.84. 1 of the 1 models that produced a value land above the price. A discount of this size counts as a positive margin of safety in every GLS scan; whether it is enough depends on the rest of the picture - the health score, the moat and the option premium below.

Only 1 of the nine models produced a value (10 Cap); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files RMTI under Speculative - it is losing money or its Piotroski health score is 3 or lower - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for RMTI

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap9.84+22%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)4.47-45%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target20.00+148%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is average - RMTI passes 5 of the nine Piotroski tests, which falls one point short of the "Piotroski 6 or more" Wheel Trade Filter. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is low at 0.8 out of 10: returns on capital, margins or the balance sheet have not shown a lasting edge yet - often a young company, a thin-margin business or one that has only recently turned profitable.

Returns on capital are thin or negative - ROIC -10.7%, ROE -14.4%, ROA -9.3% - with debt at 0.34 times equity and a free-cash-flow yield of 4.7%.

Rockwell Medical, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Reportable 100% (quarter Q1 FY2026).

Institutional ownership scores 1/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score5 / 9ROIC-10.7%
GLS Moat0.8 / 10ROE-14.4%
Debt / equity0.34ROA-9.3%
Free-cash-flow yield4.7%Payout ratio0%
Institutions1 / 10Insiders · Congress1 · 5 / 10

Wheel Score 17: Weak

RMTI scores 17 out of 100 on the Wheel Score, in the Weak band (under 50): it fails filter 1, options that actually trade - options too quiet (3 open interest, 2 a day); and filter 2, a real business, not a gamble - speculative (a loss, or a weak Piotroski score); and filter 4, financially healthy - Piotroski 5/9 (under 6); and filter 5, can repay its debt - debt with no positive cash flow to repay it; and filter 6, no serious red flags - Red Flags score 55 (under 60); and filter 7, a premium worth selling - implied volatility 500% (over 80%); and filter 8, big enough - market cap $32M (under $1.0B), and the parts are thin too - value good, premium weak, moat weak, health fair, red flags weak, option trading weak, stability weak. The score is not a judgement on the company; it says the price, quality and premium do not line up for selling puts on it today.

Implied volatility is 500%, above the 80% ceiling of the Wheel Trade Filter on premium. The premium looks generous, but moves of that size can blow through any strike. Chain open interest is thin - 3 contracts across every expiry - so fills at a fair price are not guaranteed; a 30-45-day put may not exist at a usable strike.

Volume runs at 17k shares a day on a market cap of $32M, with a beta of 1.73 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score rates that weak.

FilterWheel Trade FilterResultDetail
1Options that actually tradeFailsoptions too quiet (3 open interest, 2 a day)
2A real business, not a gambleFailsspeculative (a loss, or a weak Piotroski score)
3Below fair valuePassesTrading below the nine-model average fair value (margin of safety above 0)
4Financially healthyFailsPiotroski 5/9 (under 6)
5Can repay its debtFailsdebt with no positive cash flow to repay it
6No serious red flagsFailsRed Flags score 55 (under 60)
7A premium worth sellingFailsimplied volatility 500% (over 80%)
8Big enoughFailsmarket cap $32M (under $1.0B)
9Not a penny stockPassesShare price $5 or more
How it ranksRatingFrom
ValueGood18% below fair value
PremiumWeakimplied volatility 500%
MoatWeakmoat 0.8/10
HealthFairPiotroski 5/9
Red FlagsWeakRed Flags score 55/100
Option tradingWeak2 contracts a day, 3 open interest
StabilityWeakbeta 1.73, $32M company

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.

Upcoming events

Rockwell Medical, Inc. reports earnings on 12 Nov 2026 (before the open) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Drug Manufacturers - Specialty & Generic

The 12 companies below are the closest to Rockwell Medical, Inc. by market cap within the Drug Manufacturers - Specialty & Generic industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
RAPH
Raphael Pharmaceutical Inc.
1.51--8No options$30M
HSTI
High Sierra Technologies, Inc.
1.40--11No options$29M
CPHI
China Pharma Holdings, Inc.
0.5875--12No options$25M
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
5.21--10No options$25M
INCR
InterCure Ltd.
3.611.71-111%13Weak$43M
TXMD
TherapeuticsMD, Inc.
1.825.39+66%28Weak$21M
AYTU
Aytu BioPharma, Inc.
1.925.29+64%28No options$21M
HYEX
Healthy Extracts Inc.
1.400.6122-129%12No options$21M
TLPH
Talphera, Inc.
1.05--13Weak$55M
BIOE
Bio Essence Corporation
0.47000.8646+46%27No options$19M
ZYBT
Zhengye Biotechnology Holding Limited
1.371.27-7%13No options$65M
CPIX
Cumberland Pharmaceuticals Inc.
4.4422.07+80%26Weak$67M

⚖ Compare RMTI with 7 of them   All Healthcare stocks →

Scan the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the top 10 stocks that pass all 9 Wheel Trade Filters, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about RMTI

Is RMTI undervalued right now?

By the GLS models, moderately: at 8.05 the stock trades 18% below the average fair value of 9.84 (data as of 5 Nov 2026).

What is the Wheel Score of RMTI and what does it mean?

RMTI scores 17 out of 100 (Weak) - it fails Wheel Trade Filters 1, 2, 4, 5, 6, 7, 8. The Wheel Score ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned - in two parts: the 9 pass/fail Wheel Trade Filters (busy options, a real business, below fair value, Piotroski 6 or more, debt it can repay, a Red Flags score of 60 or more, implied volatility of 25-80%, a $1 billion company, $5 a share) and a ranking of how strongly a stock passes on value, premium, moat, health, red flags, option trading and stability. A stock that fails any filter stays under 70; 70-84 is Good, 85 and above is Prime. The Sunday Scan is the top 10 that pass, sorted by Wheel Score.

What is the GLS fair value for RMTI?

9.84 per share as of 5 Nov 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Rockwell Medical, Inc. report earnings next?

The next earnings report is due on 12 Nov 2026 (before the open), 7 days from the data date of 5 Nov 2026. The Calendars page lists every upcoming report with its time of day.

Does RMTI have listed options, and how liquid are they?

Yes. The nightly snapshot found 4 listed contracts with 3 open interest across all expiries and implied volatility of 500% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.

Data as of 5 Nov 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.